News
-
-
-
COMMUNIQUÉ DE PRESSE
Carvolix is born and funded
French medtech company Affluent Medical rebrands as Carvolix after acquiring Caranx Medical and Artedrone. Completes 10m€ financing with Truffle Capital and Edwards Lifesciences for breakthrough AI-driven mini-robots and biomimetic implants in interventional cardiology and brain stroke treatment. Focus on expanding market and long-term value creation -
-
-
COMMUNIQUÉ DE PRESSE
Affluent Medical officially becomes CARVOLIX
Affluent Medical officially becomes CARVOLIX after completing the acquisitions of CARANX MEDICAL and ARTEDRONE, with a 10m€ first tranche of financing. Carvolix focuses on revolutionizing cardiac valve replacement and brain stroke treatment -
-
-
-
